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Abstract
Background: Short stems have become more and more popular for cementless total hip arthroplasty in the past
few years. While conventional, uncemented straight stems for primary total hip arthroplasty (THA) have shown high
survival rates in the long term, it is not known whether uncemented short stems represent a reasonable alternative.
As cortical hypertrophy has been reported for short stems, the aim of this study was to determine the radiographic
prevalence of cortical hypertrophy and to assess the clinical outcome of a frequently used short, curved hip stem.
Methods: We retrospectively studied the clinical and radiographic results of our first 100 consecutive THAs
(97 patients) using the Fitmore® hip stem. Mean age at the time of index arthroplasty was 59 years (range, 19 –
79 years). Clinical outcome and radiographic results were assessed with a minimum follow-up of 2 years, and
Kaplan-Meier survivorship analysis was used to estimate survival for different endpoints.
Results: After a mean follow-up of 3.3 years (range, 2.0 – 4.4 years), two patients (two hips) had died, and three
patients (four hips) were lost to follow-up. Kaplan-Meier analysis estimated a survival rate of 100 % at 3.8 years, with
revision for any reason as the endpoint. No femoral component showed radiographic signs of loosening. No
osteolysis was detected. Cortical hypertrophy was found in 50 hips (63 %), predominantly in Gruen zone 3 and 5. In
the cortical hypertrophy group, two patients (two hips; 4 %) reported some thigh pain in combination with pain
over the greater trochanter region during physical exercise (UCLA Score 6 and 7). There was no significant
difference concerning the clinical outcome between the cortical hypertrophy and no cortical hypertrophy group.
Conclusions: The survival rate and both clinical and the radiographic outcome confirm the encouraging results for
short, curved uncemented stems. Postoperative radiographs frequently displayed cortical hypertrophy but it had no
significant effect on the clinical outcome in the early follow-up. Further clinical and radiographic follow-up is
necessary to detect possible adverse, long-term, clinical effects of cortical hypertrophy.
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Background
Uncemented, straight titanium stems are widely used for
total hip arthroplasty (THA) and have shown good to
excellent long-term survival rates [1–7]. Based on their
design, there are accepted disadvantages of conventional
straight stems, such as proximal stress shielding and loss
of bone stock, risk of fracture of the greater trochanter,
and a challenging implantation procedure by using a
minimally invasive approach [8]. Short-stem prostheses
with their metaphyseal and short diaphyseal anchoring
were developed primarily to preserve femoral bone stock
at the greater trochanter and the insertion of the gluteal
muscles by reducing the amount of bone removed dur-
ing femoral preparation [9]. In addition, short-stem
prostheses are thought to facilitate possible future revi-
sion surgery although so far there is no support in the
literature for this assumption.
The Fitmore® hip stem (Zimmer, Warsaw, IN) (Fig. 1)
is a curved, uncemented, short-stem prosthesis which
was introduced into clinical routine in 2007. Its curved
design is thought to transmit load proximally and thus
to give an optimal fit in the calcar region. Its primary
stability is presumably achieved by press-fit fixation of
the triple-tapered design [10]. With its multiple offset
options, the stem allows an offset reconstruction inde-
pendent of stem size and thus can balance soft tissue of
the hip individually [8]. To date, only few studies have
investigated the clinical and radiographic outcome for
short-stem prostheses with a mid- to long-term follow-
up. A 10-year follow-up study of the Pipino stem re-
ported an 82 % survival after 10 years [11]. The results
of the first 162 Mayo short stems published by Morrey
[12] reported revision surgery in 6 % of THAs after a 6-
year follow-up. Santori et al. [13], designers of the ultra-
short Proxima stem, did not report any instance of
femoral revision in a study group of 129 stems after a
mean follow-up of 8 years. Gustke [14] published an ex-
perience report of 500 Fitmore® hip stems, with a mean
follow-up of 1.3 years. He reported a survival rate of
99.4 % with femoral revision for any reason as the end-
point and about 29 % cortical hypertrophy of his first
100 cases. The radiological finding of cortical hyper-
trophy has been shown in the past to possibly comprom-
ise clinical outcome at both short- and long-term
follow-up.
Since uncemented straight stems have demonstrated
excellent long-term results into the third decade, newly
introduced short-stem designs need to be critically eval-
uated for their clinical and radiographic outcome. The
present study is the first to analyze the prevalence of
cortical hypertrophy and to assess the clinical outcome
of a frequently used short, curved hip stem for primary
cementless THA in order to identify any compromising
effect during early follow-up.
Patients and methods
From November 2007 to January 2009 a total of 100
consecutive primary THAs (97 patients) were per-
formed at our department, using the Fitmore® hip
stem (Zimmer, Warsaw, IN) (Fig. 1). The mean age of
the patients was 59 years at the time of index surgery
(range, 19–79 years). The mean follow-up was
3.3 years (range, 2.0–4.4 years). During the follow-up
period, two patients (two hips) had died with the
prosthesis in situ and three patients (four hips) were
lost to follow-up, leaving a total of 92 patients (94
hips) for evaluation (Fig. 2). Minimum 2-year radio-
graphic follow-up was available for 79 of the 100 hips
(79 %). Patient demographics and diagnoses are listed
in Tables 1 and 2. The patients underwent surgery
prior to being recruited for the study and all data
was collected though retrospective chart review. In-
formed written consent was obtained from all pa-
tients. The study was approved by the ethics
Fig. 1 Photograph showing the Fitmore® hip stem as a curved,
uncemented, short stem with a trapezoidal cross-section (by friendly
permission of Zimmer Biomet)
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committee at the University of Heidelberg, Germany,
and it was conducted in accordance with the Declar-
ation of Helsinki of 1975, as revised in 2008.
The Fitmore® hip stem (Zimmer, Warsaw, IN) (Fig. 1)
is a curved, uncemented, short stem with a trapezoidal
cross-section (Fig. 1). The anchorage is mainly metaphy-
seal, in the intertrochanteric region, and slightly diaphy-
seal. The primary stability of this short stem is supposed
to be achieved by a press-fit fixation of the triple-
tapered design [10]. A porolock titanium vacuum plasma
spray (Ti-VPS) coating in the proximal part was chosen
to enhance bone ongrowth. This short-stem system is
comprised of four families A, B, B-extended, and C to
respect offset variations [10]. The families were devel-
oped to address the relationship between head center
and medial curvature of the femoral canal. In this study
95 patients (98 hips) received an Allofit press-fit acetab-
ular component (Zimmer, Winterthur, Switzerland) and
two patients (2 hips) a Pinnacle acetabular cup (Depuy,
Warsaw, IN). In all patients (100 hips), a 32-mm Al2O3
ceramic head (Biolox forte®; CeramTec, Plochingen,
Germany) articulating with highly cross-linked poly-
ethylene (HXLPE) (Durasul®; Zimmer, Winterthur,
Switzerland) was used.
All operations were performed at our department by
two experienced surgeons. The standard surgical approach
was either a modified Watson-Jones [15] or a transgluteal
Bauer approach [16] with the patient in supine position.
After serial femoral broaching, an intraoperative antero-
posterior (AP) radiograph was made with the last broach
in situ to show sufficient fit in the coronal plane for
optimal press-fit of the femoral component. Full weight-
bearing was allowed directly after surgery. For routine
prophylaxis of heterotopic ossification, diclofenac 75 mg
was administered twice per day for 2 weeks. Intravenous,
third-generation cephalosporin (1.5 g cefuroxime) was ad-
ministered peri-operatively. Anticoagulation therapy con-
sisted of low-molecular-weight heparin administered
subcutaneously the day before surgery and continued for
6 weeks postoperatively.
Clinical and functional outcome was assessed by an in-
dependent observer pre- and postoperatively, including
documentation of thigh pain, Harris Hip Score (HHS)
[17], University of California, Los Angeles (UCLA) activ-
ity [18], and Tegner score [19–21]. Additionally, patients
completed a McMaster Universities Osteoarthritis index
(WOMAC) questionnaire postoperatively [22] at final
follow-up.
For radiographic evaluation, standard pelvic AP and
lateral radiographs of the hip were taken directly
postoperatively and at final follow-up. Radiolucent
lines or osteolysis at the femoral bone-prosthesis
interface as well as cortical hypertrophy were evalu-
ated by two independent, blinded observers (MM,
MS) using the zones described by Gruen et al. [23] as
Fig. 2 Distribution of hips at final follow-up
Table 1 Patient demographics
Demographics Male Female Total/mean (range)
Age, mean (range) 56 (23–78) 58 (19–79) 59 (19–79)
Hips 55 45 100
Table 2 Patient demographics
Diagnoses Number of hips (%)
Osteoarthritis 48 (48 %)
Avascular Necrosis 7 (7 %)
Dysplasia Hip 37 (37 %)
Posttraumatic OA 4 (4 %)
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previously described by our study group [24]. Femoral
osteopenia due to stress shielding and femoral com-
ponent fixation were graded according to the criteria
described by Engh et al. [25, 26]; femoral loosening
was defined as progressive axial subsidence of more
than 5 mm according to the description of Malchau
et al. [27] or varus or valgus tilting. Furthermore,
heterotopic ossification was assessed according to
Brooker et al. [28].
Statistical analysis
Kaplan-Meier survivorship analysis was used to estimate
survival for different end points: stem revision for any
reason, revision for aseptic loosening, and reoperation
on the hip for any other cause (e.g., liner exchange, in-
fection, periprosthetic fracture, or dislocation). Revision
was defined as an operation that involved removal and/
or replacement of one or more components of the cup,
inlay, head, or stem. The data were not normally distrib-
uted, and Wilcoxon rank-sum test was used to compare
pre- and postoperative clinical scores and the postopera-
tive scores between the cortical hypertrophy and no cor-
tical hypertrophy group. We considered p-values of
<0.05 to be significant. SPSS® Version 17.0 (SPSS Inc,
Chicago, IL, U.S.A.) and Graphpad Prism® Version 5.0
(Graphpad Software, La Jolla, CA, U.S.A.) were used to
record and analyze the collected data.
Results
Sample
At a minimum follow-up of 2 years, two patients (two
hips) had died with the prosthesis in situ, and three pa-
tients (four hips) were lost to follow-up as they had
moved to foreign countries (Fig. 2). Thus, 94 hips in 92
patients were available for review at a mean follow-up of
3.3 years (range, 2.0–4.4 years). In all, 78 patients (79
hips) were available for both clinical and radiographic
evaluation, leaving 14 patients (15 hips) for clinical
evaluation without radiographs (Fig. 2). The distribution
of our patients to the 4 Fitmore® families A, B, B-
extended, and C and the stem sizes is shown in Fig. 3.
Revisions
Of all 100 THAs there have been no reports (0 %) of fem-
oral stem revisions. In one hip (one patient) a reoperation
was performed for hematoma 3 days after index surgery.
There were no intraoperative complications, in particular
no proximal femoral fracture during insertion of the new,
short, curved, uncemented hip stem. No early or late in-
fection was observed, and at final follow-up no isolated re-
vision of the cup or inlay had been performed.
Survival analysis
The Kaplan-Meier survival analysis with femoral revision
for any reason as the endpoint estimated a survival rate
of 100 % at 3.8 years (20 hips at risk) (Fig. 4). The
Fig. 3 Distribution of the Fitmore® hip stem families and stem sizes
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survival rate with reoperation for any reason as the end-
point was 99 % at 3.8 years (95 % confidence interval
[CI], 93–100 %; 20 hips at risk) (Fig. 5). Worst-case sur-
vival of the femoral component, considering all patients
that were lost to follow-up as revised, was 96 % at
3.8 years (95 % confidence interval [CI], 90–98 %; 20
hips at risk) (Fig. 6).
Radiographic evaluation
Figure 7 shows a representative AP hip radiograph pre-
operatively and postoperatively at final follow-up. Radio-
graphic evaluation did not show any acetabular or
femoral component loosening at a minimum of 2 years.
All implants demonstrated complete osseous ingrowth.
No femoral or periacetabular osteolysis or radiolucent
lines >2 mm were detected in any hip. Radiolucent lines
<2 mm around the femoral component were found in 20
of 79 hips (25 %), predominantly in Gruen zone 1, 5,
and 7 (Fig. 8). Cortical hypertrophy was found in 50 hips
(63 % of the 79 hips with radiological review), predomin-
antly in Gruen zone 3 and 5 (Fig. 8). Figure 7 shows the
cortical hypertrophy typically found in Gruen zone 3
and 5. Thirteen hips (17 %) showed both distal cortical
hypertrophy and proximal radiolucent lines (<2 mm).
Heterotopic ossification was found in 15 of 79 hips
(19 %) and was graded according to Brooker as grade I
(12 hips), II (1 hips), and III (2 hips).
Clinical evaluation
The mean total Harris hip score (HHS) improved signifi-
cantly from 56 points preoperatively (range, 14 -80
points) to 94 points postoperatively (range, 62 -100
points, paired Student t-test, p < 0.005). There was no
significant difference in postoperative HHS between the
cortical hypertrophy (94 points) and no cortical hyper-
trophy (93 points) group (p = 0.846). Two patients (2 %)
reported some thigh pain in combination with pain at
the greater trochanter during physical exercise (UCLA
Score 6 and 7). Both patients demonstrated typical cor-
tical hypertrophy located in Gruen zone 3. The mean
preoperative UCLA activity and Tegner score increased
significantly from 3.7 (range 2 – 7) preoperatively to 6.7
(range 2 – 10) postoperatively (p < 0.005) and from 2.7
(range 1 – 6) to 4.4 (range 2 – 8) (p = 0.02), respectively.
The mean postoperative WOMAC Score was 93 (range
58.3 – 100). There was no significant difference in post-
operative UCLA, Tegner, and WOMAC scores between
the cortical hypertrophy and no cortical hypertrophy
groups.
Discussion
Short, curved, femoral stems were designed to preserve
femoral bone stock [9, 13]. Preserving the femoral neck
provides greater torsional stability and may reduce distal
Fig. 4 Kaplan-Meier survivorship curve with femoral revision for any
reason as the endpoint. The 3.8-year survival was estimated at 100 %
(20 hips at risk)
Fig. 5 Kaplan-Meier survivorship curve and 95 % CI with reoperation
for any reason as the endpoint. The 3.8-year survival was estimated
at 99 % (95 %-CI, 93–100 %; 20 hips at risk)
Fig. 6 Kaplan-Meier survivorship curve and 95 % CI with worst-case
survival of the femoral component (considering all patients that
were lost to follow-up as revised). The 3.8-year survival was
estimated at 96 % (95 %-CI, 90–98 %; 20 hips at risk)
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migration of the femoral stem [29]. Metaphyseal femoral
loading independent of fixation of the stem may help to
reduce resorption of proximal bone due to stress shield-
ing [12, 25, 30]. Currently, short stems have become
popular in clinical routine but there are only few re-
ports concerning their clinical and radiographic out-
come [9, 11–14, 31–35]. The clinical relevance of the
present study is the fact that recently published data
have indicated the presence of cortical hypertrophy
with the Fitmore® hip stem [14] during early follow-
up. The aim of this study, therefore, was to determine
the prevalence of cortical hypertrophy in the early
follow-up and to assess the clinical outcome of this
short stem for primary cementless THA in order to
identify any compromising effect on the clinical
outcome.
In our study, femoral cortical hypertrophy was ob-
served in 63 % of hips, being mainly located at the distal
part of the stem (Gruen zone 3 and 5). There was no
significant difference concerning the clinical outcome
between the cortical hypertrophy and no cortical hyper-
trophy group. Two of the cortical hypertrophy patients
(4 %) reported some thigh pain in combination with pain
at the greater trochanter during physical exercise (UCLA
Score 6 and 7). Pipino et al. reported a much higher rate
of 14 % persistent thigh pain after 10 years, compared to
4 % in the present series. A similarly low percentage of
thigh pain was reported for the uncemented straight
titanium Zweymüller stem, showing isolated thigh
pain in 1 % of patients after 20 years Thigh pain is
known to be related to stem design and implant stiff-
ness [37, 38]. Pipino et al. [11] reported on distal cor-
tical hypertrophy in 48 % of his patients, mainly in
Gruen zone 2, 3 and 5. In his long-term follow-up
study, he found thigh pain in 14 % directly after sur-
gery, which spontaneously resolved within 1 year.
Among his patients with thigh pain, one had an over-
sized stem with consequential tip wedging, while five
had undersized, varus stems. In three of these latter
cases, radiographs showed demarcation lines associ-
ated with cortical hypertrophy in zones 3 and 5.
Pipino et al. interpreted thigh pain to be an expres-
sion of transitory instability of the stem, rather than a
phenomenon related to tip wedging of the prosthesis.
Gustke [14] reported 29 % cortical hypertrophy in his
first 100 cases, with only few patients showing distal
cortical hypertrophy and proximal cortical atrophy. In
the present study, 13 hips showed distal cortical
hypertrophy and proximal radiolucent lines (>2 mm)
at the same time. Gustke concluded that in these
cases, the stem could be fixed more distally. We con-
clude that these hips need to be reexamined in a
shorter follow-up period to detect a potentially higher
risk of loosening. In the present study, more than
60 % of the hips showed cortical hypertrophy but it
had no significant effect on the clinical outcome in
the early follow-up period.
In the present series, the Kaplan-Meier analysis, with
femoral revision for any reason as the endpoint, revealed
an excellent survival rate of 100 % at 3.8 years. The sur-
vival rate with reoperation for any reason as the end-
point was very good at 99 %. In the literature, only one
report has been published. Gustke [14] followed up 500
Fitmore® hip stems, with a mean follow-up period of
1.3 years. He reported a survival rate of 99.4 % with fem-
oral revision for any reason as the endpoint, comparing
well to our results. However, a comparison with the re-
sults of the present study is difficult since distribution of
stem types was considerably different and the mean
follow-up interval differed as well. Furthermore, Gustke
Fig. 7 Anteroposterior hip radiographs of a 65-year-old woman with
primary OA (a), directly postoperatively (b), 1 year (c), and 4 years (d)
after surgery. The postoperative follow-up ((c) and (d)) shows the
typical cortical hypertrophy mainly located in Gruen zone 3 and 5
and radiolucency < 2 mm in Gruen zone 1
Maier et al. BMC Musculoskeletal Disorders  (2015) 16:371 Page 6 of 9
reported two patients who sustained a periprosthetic
fracture after falls that subsequently required stem revi-
sion. One patient had a late infection. In that series,
there were no revisions for aseptic loosening. In the
present series, there was no periprosthetic fracture, no
infection, and no isolated revisions of the cup or inlay
after a mean follow-up of 3.3 years.
In the literature to date, long-term follow-up studies
of short stems are rare: There is one long-term follow-
up study of the first short stem developed, the Pipino
stem, showing an 82 % survival rate at 10 years [11].
The results of the first 162 Mayo short stems published
by Morrey [12] reported revision surgery in 6 % of
THAs, due to wear-induced loosening. Mechanical fail-
ure of the stem resulted in stem revision in three pa-
tients (2 %). Intraoperative fracture of the femur
occurred in 10 cases (6 %). None of these patients com-
plained of thigh pain. Santori et al. [13], designers of the
ultra-short Proxima stem, did not mention any femoral
revision in a study group of 129 stems, whereas a total
of five hips had to be revised, three for polyethylene liner
exchange and two for acetabular loosening [13].
In cementless short-stem prostheses, preserving the
femoral neck should provide greater torsional stability
and reduce distal migration of the femoral stem [29].
The idea underlying reduced diaphyseal fixation is to
achieve proximal load transfer and to reduce stress
shielding and thigh pain [9]. In the present study, radio-
graphic evaluation did not show any femoral component
loosening, and all implants revealed osseous ingrowth.
No femoral osteolysis or radiolucent lines >2 mm were
detected; radiolucent lines <2 mm around the femoral
component were found in 25 %, predominantly in Gruen
zone 1, 5 and 7. Factors related to patients, implant de-
sign, and implantation did not predict migration pat-
terns. Bieger et al. [39] compared the Fitmore® hip stem
to a conventional straight CLS® stem (Zimmer) in a bio-
mechanical study and showed that the Fitmore® hip stem
was as stable as the CLS® stem to tilting in the frontal
and sagittal plane and more stable to rotation. The
shorter Fitmore® stem showed a lower reduction in the
surface strain proximally than the straight stem, indicat-
ing that the shorter stem may have less proximal stress
shielding. Pepke and Nadorf [40] showed bending results
that support the hypothesis that the CLS stem presum-
ably closely follows the bending of the bone, whereas the
shorter Fitmore stem acts more rigidly. They concluded
that stem rigidity and flexibility need to be considered,
as they may influence the load transfer at the implant-
bone interface and thus possibly affect bone remodeling
Fig. 8 Radiographic evaluation of the radiolucent lines (RL) and cortical hypertrophy (CH) findings in Zones according to Gruen et al
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processes. One of the original ideas behind the design
criteria of short stems was to render loading of the prox-
imal femoral bone as physiological as possible, with the
aim to reduce stress shielding. However, cortical hyper-
trophy in the distal Gruen zones implies distal loading
and proximal stress bypass. As a limitation of the
present study, we only assessed osteolysis on conven-
tional X-rays, which has been shown to be less reliable
[41–43]. Albanes et al. [44] showed in a DEXA (dual-en-
ergy absorptiometry) study on six different short-stem
designs a bone mineral density (BMD) loss that is larger
for some designs than for conventional stems. Calcula-
tions with FE (finite element) models for the Nanos
short stem predicted a bone loss of 30–69 % in Gruen
zones 1 and 7 compared to the normal femur [45]. This
was confirmed by Tsao et al. with the Mayo hip [46]. A
prospective cohort study on the short CFP stem using
RSA (radiostereometric analysis) and DEXA [47] con-
cluded that there was substantial loss in proximal BMD
(Gruen zone 7: 31 %) and explained this by distally
transmitted forces, which would explain the cortical
hypertrophy in this study. This was also seen in a pro-
spective 7-year follow-up with qCT-assisted densitom-
etry in 38 CFP stems which showed cancellous BMD
loss of 66 % and cortical BMD loss of 27 %, being pro-
gressive until 3 years [48]. Their conclusion was that
density changes suggest diaphyseal fixation below the
lesser trochanter with high proximal bone loss. In the
mid- to long-term follow-up, this may evolve into defi-
cient bone support for short stems which rely on prox-
imal fixation.
Currently, the migration pattern of the Fitmore® stem
design is still unknown. It has been suggested that there
is an association between early excessive migration and
medium- to long-term loosening of prosthetic joints
[39–41] and that the outcome could be predicted by
measuring early migration. Freeman et al. [40] suggested
that any new femoral prosthesis should be monitored on
introduction, by measuring its migration rate in a num-
ber of patients over a period of 2 years, and that rapidly
migrating components should be abandoned forthwith.
If RSA is used to measure migration, the increased ac-
curacy and precision increase the predictive power [42].
Therefore, RSA studies with the Fitmore® stem are ne-
cessary to assess the migration patterns and to predict
long-time survival. Considering the heterogeneous group
of differently designed, short hip stems, a direct com-
parison of the results is difficult. Since uncemented
straight stems have demonstrated excellent long-term
results into the third decade, the requirements for new
short stems are high and every outcome study must be
evaluated critically.
The present study has some limitations. We only con-
ducted a radiological investigation of cortical hypertrophy.
As evidence from radiological investigations using con-
ventional x-rays are limited without RSA or DEXA meas-
urement, the results need to be interpreted with caution.
Retrospective, observational studies have an inherent risk
of selection bias, as the ideal patients are selected for these
procedures, and of expertise bias, as the operations in this
study were performed by hip surgeons with special inter-
est and skills in THA. Furthermore, the conclusions of the
study are only restricted to short-term results and as cor-
tical hypertrophy is found frequently, radiographic follow-
up is required to detect possible long-term clinical effects
of cortical hypertrophy.
Conclusion
The survival rate and the clinical and the radiographic
outcome confirm encouraging results for short, curved,
uncemented stems. Postoperative radiographs frequently
displayed cortical hypertrophy but it had no significant
effect on the clinical outcome at early follow-up. Further
clinical and radiographic follow-up and RSA studies are
needed to detect possible adverse, long-term clinical
effects of cortical hypertrophy.
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